Ovarian Cancer Research Alliance (OCRA) President and CEO Audra Moran, along with members of the OCRA team, joined leading scientists and non-profit executives from across the globe this October at the Helene Harris Memorial Trust (HHMT) International Forum on Ovarian Cancer. This prestigious conference, organized by Ovarian Cancer Action, convened in Surrey, United Kingdom, where experts gathered to discuss the latest advancements in ovarian cancer research and explore new avenues for collaboration that could accelerate the search for a cure.
The event brought together dozens of researchers and influential figures from around the world, including the CEOs of Ovarian Cancer Canada, Australia’s Ovarian Cancer Research Foundation, the UK-based Ovarian Cancer Action, and OCRA. This rare assembly of leaders provided a platform for sharing groundbreaking research and collective insights. As the only ovarian cancer conference of its kind focused on international cooperation, the HHMT Forum exemplified the power of shared goals and interdisciplinary teamwork in the fight against ovarian cancer.
“International cooperation is so key, especially in this era of big data and AI,” said Moran. “That’s how we’re going to move the science forward faster.” Moran’s words underscored the importance of uniting global expertise to address complex challenges in ovarian cancer research, where advances in data analytics and artificial intelligence offer unprecedented opportunities to unlock critical discoveries.
Throughout the forum, participants highlighted how combining diverse skill sets and perspectives from across the globe strengthens research efforts, enabling breakthroughs that would be impossible in isolation. This collaborative spirit, fostered through the HHMT Forum, promises to drive discoveries that offer hope to ovarian cancer patients worldwide and inspire a new wave of innovative research in the years to come.
